Sweeney C - Search Results

1

Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.

Zhang S, Zeng G, Kao C, Gardner T, Sweeney C, Yang NS, Eble JN, Cheng L. Zhang S, et al. Among authors: sweeney c. Prostate. 2002 Sep 15;53(1):69-76. doi: 10.1002/pros.10132. Prostate. 2002. PMID: 12210482

2

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M, Nakshatri H, Cheng L. Sweeney C, et al. Clin Cancer Res. 2004 Aug 15;10(16):5501-7. doi: 10.1158/1078-0432.CCR-0571-03. Clin Cancer Res. 2004. PMID: 15328189

3

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.

Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Yip-Schneider MT, et al. Among authors: sweeney cj. Carcinogenesis. 2000 Feb;21(2):139-46. doi: 10.1093/carcin/21.2.139. Carcinogenesis. 2000. PMID: 10657949

4

A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.

Pan CX, Loehrer P, Seitz D, Helft P, Juliar B, Ansari R, Pletcher W, Vinson J, Cheng L, Sweeney C. Pan CX, et al. Among authors: sweeney c. Oncology. 2005;69(1):63-70. doi: 10.1159/000087302. Epub 2005 Aug 2. Oncology. 2005. PMID: 16088234 Clinical Trial.

5

Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.

Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL, Marshall MS. Yip-Schneider MT, et al. Among authors: sweeney cj. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85. J Pharmacol Exp Ther. 2001. PMID: 11504793

6

Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.

Watson C, Miller DA, Chin-Sinex H, Losch A, Hughes W, Sweeney C, Mendonca MS. Watson C, et al. Among authors: sweeney c. Radiat Res. 2009 Apr;171(4):389-96. doi: 10.1667/RR1394.1. Radiat Res. 2009. PMID: 19397439

7

Chemotherapy in non-small cell lung cancer.

Sweeney CJ, Sandler AB. Sweeney CJ, et al. Invest New Drugs. 2000 May;18(2):157-86. doi: 10.1023/a:1006330030333. Invest New Drugs. 2000. PMID: 10857995 Review. No abstract available.

8

Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.

Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Yip-Schneider MT, et al. Among authors: sweeney cj. Int J Oncol. 1999 Aug;15(2):271-9. doi: 10.3892/ijo.15.2.271. Int J Oncol. 1999. PMID: 10402237

9

The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.

Miller KD, Sweeney CJ, Sledge GW Jr. Miller KD, et al. Among authors: sweeney cj. Ann Oncol. 2003 Jan;14(1):20-8. doi: 10.1093/annonc/mdg033. Ann Oncol. 2003. PMID: 12488288 Free article. Review.

10

Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.

Estabrook NC, Chin-Sinex H, Borgmann AJ, Dhaemers RM, Shapiro RH, Gilley D, Huda N, Crooks P, Sweeney C, Mendonca MS. Estabrook NC, et al. Among authors: sweeney c. Free Radic Biol Med. 2011 Dec 15;51(12):2249-58. doi: 10.1016/j.freeradbiomed.2011.09.029. Epub 2011 Oct 1. Free Radic Biol Med. 2011. PMID: 22019440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,179 results

Search Page

Filters